Evidence map›Paper›PMID 42496252›Full record

ArticleAdvances in respiratory medicine2026

Utilization Patterns of Nebulized Glycopyrronium in Patients Hospitalized for Acute Exacerbations of Obstructive Airway Disease (AEOAD)-Indian Expert Perspectives.

Arjun Khanna, Pradyut Waghray, Ashok Kr Singh, Jinay Mehta, Rithik, Sagar Bhagat, Saiprasad Patil, Hanmant Barkate

Abstract read
In one paragraph

Article in Advances in respiratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Arjun KhannaDepartment of Pulmonary Medicine, School of Medicine, Amrita Vishwa Vidyapeetham, Faridabad 121002, Haryana, India.
Pradyut WaghrayPulmonary Medicine SVS Medical College, Mahbubnagar 509001, Telangana, India.
Ashok Kr SinghPulmonary & Critical Care Medicine Regency Hospital, Kanpur 208005, Uttar Pradesh, India.ORCID 0000-0003-0510-5509
Jinay MehtaGlobal Medical Affairs, Glenmark Pharmaceuticals, Ltd., Mumbai 400099, Maharashtra, India.
RithikGlobal Medical Affairs, Glenmark Pharmaceuticals, Ltd., Mumbai 400099, Maharashtra, India.
Sagar BhagatGlobal Medical Affairs, Glenmark Pharmaceuticals, Ltd., Mumbai 400099, Maharashtra, India.
Saiprasad PatilGlobal Medical Affairs, Glenmark Pharmaceuticals, Ltd., Mumbai 400099, Maharashtra, India.
Hanmant BarkateGlobal Medical Affairs, Glenmark Pharmaceuticals, Ltd., Mumbai 400099, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bronchodilator AgentsGlycopyrrolateMuscarinic AntagonistsPractice Patterns, Physicians'Pulmonary Disease, Chronic ObstructiveAdministration, InhalationHospitalizationHumansIndiaNebulizers and VaporizersBronchodilator AgentsGlycopyrrolateMuscarinic Antagonistsacute exacerbationconsensus statementIndia-specific evidenceinpatient managementlong-acting muscarinic antagonistnebulized glycopyrroniumobstructive airway diseasetriple therapy

Identifiers

PMID42496252
PMCPMC13398247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.